covid
Allergologia et Immunopathologia Omalizumab beyond asthma
Journal Information

Statistics

Follow this link to access the full text of the article

Review
Omalizumab beyond asthma
J. Sancheza,b,c, R. Ramireza, S. Dieza, S. Susa, A. Echeniquea, M. Olivaresa,d, R. Cardonaa,d,
Corresponding author
ricardona@une.net.co

Corresponding author.
a Group of Clinical and Experimental Allergology (GACE), Medellín, Colombia
b Foundation for Development of Medical and Biological Sciences (FUNDEMEB), Cartagena, Colombia
c University of Cartagena, Institute for Immunological Research, Cartagena, Colombia
d Medical School, University of Antioquia, Medellín, Colombia
Read
11648
Times
was read the article
3809
Total PDF
7839
Total HTML
Share statistics
Article information
ISSN: 03010546
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 101 118 219
2025 11 341 457 798
2025 10 132 219 351
2025 9 99 275 374
2025 8 147 239 386
2025 7 174 122 296
2025 6 121 38 159
2025 5 131 21 152
2025 4 93 4 97
2025 3 100 8 108
2025 2 94 3 97
2025 1 95 5 100
2024 12 99 5 104
2024 11 68 9 77
2024 10 65 19 84
2024 9 62 19 81
2024 8 50 23 73
2024 7 74 13 87
2024 6 78 12 90
2024 5 96 6 102
2024 4 66 8 74
2024 3 86 18 104
2024 2 102 32 134
2024 1 108 13 121
2023 12 102 20 122
2023 11 162 25 187
2023 10 164 34 198
2023 9 58 13 71
2023 8 63 13 76
2023 7 85 17 102
2023 6 66 17 83
2023 5 151 9 160
2023 4 143 3 146
2023 3 109 3 112
2023 2 68 8 76
2023 1 67 16 83
2022 12 25 10 35
2022 11 30 13 43
2022 10 24 7 31
2022 9 27 21 48
2022 8 15 19 34
2022 7 26 22 48
2022 6 36 6 42
2022 5 21 9 30
2022 4 23 15 38
2022 3 52 10 62
2022 2 36 4 40
2022 1 65 9 74
2021 12 19 31 50
2021 11 30 32 62
2021 10 30 36 66
2021 9 30 76 106
2021 8 44 13 57
2021 7 11 31 42
2021 6 9 14 23
2021 5 13 25 38
2021 4 13 82 95
2021 3 15 25 40
2021 2 31 41 72
2021 1 6 42 48
2020 12 0 17 17
2020 11 0 21 21
2020 10 0 11 11
2020 9 0 53 53
2020 8 0 6 6
2020 7 0 7 7
2020 6 1 14 15
2020 5 0 8 8
2020 4 0 8 8
2020 3 0 5 5
2020 2 0 6 6
2020 1 0 6 6
2019 12 0 7 7
2019 11 0 2 2
2019 10 0 4 4
2019 9 0 8 8
2019 8 0 3 3
2019 7 0 7 7
2019 6 0 13 13
2019 5 0 30 30
2019 4 0 4 4
2018 8 0 1 1
2018 3 0 1 1
2018 2 12 10 22
2018 1 13 2 15
2017 12 14 8 22
2017 11 11 15 26
2017 10 28 10 38
2017 9 16 19 35
2017 8 18 19 37
2017 7 15 19 34
2017 6 27 20 47
2017 5 39 27 66
2017 4 25 41 66
2017 3 18 99 117
2017 2 39 15 54
2017 1 12 18 30
2016 12 22 13 35
2016 11 57 22 79
2016 10 77 25 102
2016 9 67 16 83
2016 8 38 11 49
2016 7 21 11 32
2016 6 51 17 68
2016 5 35 19 54
2016 4 54 22 76
2016 3 57 14 71
2016 2 45 23 68
2016 1 48 32 80
2015 12 36 18 54
2015 11 67 28 95
2015 10 49 22 71
2015 9 52 12 64
2015 8 61 17 78
2015 7 86 11 97
2015 6 50 111 161
2015 5 72 18 90
2015 4 69 12 81
2015 3 105 9 114
2015 2 43 8 51
2015 1 18 6 24
2014 12 19 7 26
2014 11 12 6 18
2014 10 14 8 22
2014 9 26 8 34
2014 8 22 11 33
2014 7 10 8 18
2014 6 12 4 16
2014 5 17 8 25
2014 4 18 7 25
2014 3 132 25 157
2014 2 133 22 155
2014 1 120 11 131
2013 12 119 9 128
2013 11 86 10 96
2013 10 78 27 105
2013 9 74 25 99
2013 8 46 15 61
2013 7 51 19 70
2013 6 53 6 59
2013 5 81 11 92
2013 4 62 13 75
2013 3 30 8 38
2013 2 22 8 30
2013 1 9 4 13
2012 12 8 4 12
2012 11 3 4 7
2012 10 3 2 5
2012 9 1 1 2
2012 8 559 0 559
Show all

Follow this link to access the full text of the article